Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Suggett (London (ON), Canada), V. Kushnarev (London (ON), Canada), C. Van Holsbeke (Kontich, Belgium), S. Van Steen (Kontich, Belgium), B. Mignot (Kontich, Belgium). The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type. 4015

Member's Comments

No comment yet.

Related content which might interest you: Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use. Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Comparison of the long-term efficacy and safety of ipratropium bromide (IB) delivered by a new soft mist inhaler (SMI) versus conventional metered dose inhaler (MDI) in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 69s Year: 2001 Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation. Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC) Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Comparison of the efficacy and safety of ipratropium bromide (IB)/fenoterol hydrobromide (FEN) delivered by a new soft mist inhaler (SMI) or a conventional metered dose inhaler (MDI) in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 70s Year: 2001 Dose- and exposure response analysis of glycopyrrolate (GP) metered dose inhaler (MDI) to support optimal dosing in patients with COPD for combination product development Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II Year: 2010 Differences in patient perceived side effects (PPSE) of inhaled corticosteroids (ICS) between metered dose inhalers (MDI) and dry powder inhalers (DPI) Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC) Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Two-tone trainer maintains a slow inhalation rate when using a metered dose inhaler (MDI) Source: Eur Respir J 2005; 26: Suppl. 49, 47s Year: 2005 In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019 Lung deposition of two bronchodilators in subjects with (COPD) when administered via standard jet nebulizer or Handihaler® using functional respiratory imaging (FRI). Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Pharmacokinetics (PK) of a single dose AZD7594 administered intravenously (IV), orally, and inhaled via two dry powder inhalers (DPI) and a pressurized metered-dose inhaler (pMDI) Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008